CHLOROPTIC
LOE ApproachingNDAOPHTHALMICSOLUTION/DROPS
Approved
Mar 1968
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 4d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CHLOROPTIC is an ophthalmic solution approved in 1968 for eye infection and inflammation treatment. The specific mechanism of action and indications are not publicly documented in available data. It is administered as topical eye drops.
LOE Approaching
This legacy product approaching loss of exclusivity presents limited growth opportunities; team size and hiring activity are likely minimal as focus shifts to pipeline products.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
CHLOROPTIC currently has zero linked job openings, reflecting its late-stage lifecycle and approaching loss of exclusivity. Working on this product offers limited career growth, with roles focused on managing decline rather than expansion.
Brand ManagerField Sales Representative
Worked on CHLOROPTIC at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.